Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Cash flows from operating activities:    
Net loss $ (9,677) $ (21,955)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of convertible debentures 711
Depreciation and amortization of property, plant and equipment 537 1,428
Share-based compensation charges 1,336 945
Share-based 401(k) employer match expense 362 396
Unrealized foreign exchange loss (gain) 240 (707)
(Gain) on operating lease terminations (554)
Changes in operating assets and liabilities:    
Accounts receivable 1,252 653
Inventories 192 (310)
Prepaid expenses and other assets (272) 1,080
Accounts payable – trade (7,097) 4,678
Accrued liabilities, other current liabilities and other liabilities (9,342) (1,099)
Total adjustments (12,635) 7,064
Net cash used in operating activities (22,312) (14,891)
Cash flows from investing activities:    
Capital expenditures (279) (1,521)
Net cash used in investing activities (279) (1,521)
Cash flows from financing activities:    
Repayments under mortgage agreement and capital leases (73) (157)
Cash payments for taxes related to net share settlements of equity awards (467)
Net cash used in financing activities (540) (157)
Effect of exchange rate changes on cash and cash equivalents (1) 20
Decrease in cash and cash equivalents and restricted cash (23,132) (16,549)
Cash and cash equivalents and restricted cash - beginning of period 83,373 22,603
Cash and cash equivalents and restricted cash - end of period 60,241 6,054
Composition of cash and cash equivalents and restricted cash is as follows:    
Cash and cash equivalents 60,241 5,054
Restricted cash 1,000
Total cash and cash equivalents and restricted cash $ 60,241 $ 6,054